Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Return on Sales (2024 - 2025)

Historic Return on Sales for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to 0.52%.

  • Beta Bionics' Return on Sales rose 900.0% to 0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.67%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.63% for FY2024, which is 22100.0% up from last year.
  • Beta Bionics' Return on Sales amounted to 0.52% in Q3 2025, which was up 900.0% from 0.73% recorded in Q2 2025.
  • Beta Bionics' 5-year Return on Sales high stood at 0.52% for Q3 2025, and its period low was 0.92% during Q1 2025.